WEST PALM BEACH, FL: FTI Consulting has named Barbara Ryan MD in its strategic communications unit.
Based in New York, Ryan will support FTI's healthcare and life sciences transactions and crisis communications offerings.
Ryan was previously MD and head of the pharmaceutical research team at Deutsche Bank for the past 20 years. In that role, she published pharmaceutical research, led the firm's annual healthcare conference, conducted marketing activities for institutional clients, and served as the lead analyst on several IPOs.
Previously, Ryan held pharmaceutical analyst positions at Prudential Securities and Bear Stearns.